Mid-Market Update: Shares of Valeant Pharmaceuticals (VRX, $34.51, down $34.53) have been volatile in recent weeks and months after the company fell under scrutiny with investors.

This content is for Momentum Options – 6 Months, Momentum Options – 1 Year and Momentum Options – 2 Years members only.
Log In Register